The Spectrum of Alcohol Associated Liver Disease
-
Register
- User - $30
This session discusses the diagnosis and treatment of alcohol associated liver disease. Included in this session the complications of liver disease and treatment options are discussed in detail for the outpatient and inpatient setting.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education. The expiration date below is for the product and doest not affect your 90 days access.
Credits: 1.00 Contact Hours; 0.50 are Pharmacology
This activity is designated for 18 AAPA Category 1 CME credits. Approval is valid from 6/9/2025 to 6/8/2026. PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: June 26, 2026
$30
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-To recognize the spectrum and consequences of alcohol associated illness including:
-Fatty Liver Disease
-Cirrhosis and its consequences
Variceal bleeding
Hepatorenal syndrome
Spontaneous bacterial peritonitis
Peter Buch, MD, FACG, AGAF, FACP
Associate Professor
Quinnipiac University, Frank H. Netter MD School of Medicine
Dr Peter Buch is a clinical gastroenterologist with over 35 years of teaching experience. Teaching is his passion! His style is case based, practical, very interactive and fun. Dr Buch is a nationally known speaker who has been honored to teach at NPACE previously. He has taught at the University of Connecticut APRN School and has mentored dozens of APRNs. He is a Clinical Professor at the ECHN campus of UNECOM He is also an Associate Clinical Professor at the University of Connecticut School of Medicine and the Frank H Netter, MD School of Medicine. Dr Buch always learns from his audience and looks forward to learning with you!
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid from 6/9/2025 to 6/8/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid from 6/9/2025 to 6/8/2026 .
DISCLOSURES
Faculty
Contributing faculty, Peter Buch MD, FACG, AGAF, FACP has no financial relationship to disclosed.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
